Publications 2020

Wise JF, Nakken S, Steen CB, Vodak D, Troen G, Johannessen B, Lingjxrde OC, Hilden V, Blaker YN, Bai BY, Aasheim LB, Pasanen A, Lorenz S, Sveen A, Lothe RA, Myklebost O, Leppa S, Meza-Zepeda LA, Beiske K, Lawrence MS, Hovig E, Myklebust JH, Smeland EB, Holte H (2020)
Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series
Blood Adv., 4 (9), 1859-1866
DOI 10.1182/bloodadvances.2019001325

Publications 2017

Bollum LK, Huse K, Oksvold MP, Bai BY, Hilden VI, Forfang L, Yoon SO, Walchli S, Smeland EB, Myklebust JH (2017)
BMP-7 induces apoptosis in human germinal center B cells and is influenced by TGF-beta receptor type I ALK5
PLoS One, 12 (5), e0177188
DOI 10.1371/journal.pone.0177188

Taraldsrud E, Fevang B, Jorgensen SF, Moltu K, Hilden V, Tasken K, Aukrust P, Myklebust JH, Olweus J (2017)
Defective IL-4 signaling in T cells defines severe common variable immunodeficiency
J. Autoimmun., 81, 110-119
DOI 10.1016/j.jaut.2017.04.004

Publications 2014

Bethge N, Honne H, Andresen K, Hilden V, Troen G, Liestol K, Holte H, Delabie J, Lind GE, Smeland EB (2014)
A Gene Panel, Including LRP12, Is Frequently Hypermethylated in Major Types of B-Cell Lymphoma
PLoS One, 9 (9), e104249
DOI 10.1371/journal.pone.0104249

Brodtkorb M, Lingjaerde OC, Huse K, Troen G, Hystad M, Hilden VI, Myklebust JH, Leich E, Rosenwald A, Delabie J, Holte H, Smeland EB (2014)
Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma
Blood, 123 (7), 1051-1054
DOI 10.1182/blood-2013-07-512392

Publications 2013

Bethge N, Honne H, Hilden V, Troen G, Eknaes M, Liestol K, Holte H, Delabie J, Smeland EB, Lind GE (2013)
Identification of Highly Methylated Genes across Various Types of B-Cell Non-Hodgkin Lymphoma
PLoS One, 8 (11), e79602
DOI 10.1371/journal.pone.0079602

Yri OE, Ekstrom PO, Hilden V, Gaudernack G, Liestol K, Smeland EB, Holte H (2013)
Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab
Leuk. Lymphoma, 54 (10), 2205-2214
DOI 10.3109/10428194.2013.774392

Publications 2012

Bakkebo M, Huse K, Hilden VI, Forfang L, Myklebust JH, Smeland EB, Oksvold MP (2012)
SARA is dispensable for functional TGF-beta signaling
FEBS Lett., 586 (19), 3367-3372
DOI 10.1016/j.febslet.2012.07.027

Huse K, Bakkebo M, Walchli S, Oksvold MP, Hilden VI, Forfang L, Bredahl ML, Liestol K, Alizadeh AA, Smeland EB, Myklebust JH (2012)
Role of Smad Proteins in Resistance to BMP-Induced Growth Inhibition in B-Cell Lymphoma
PLoS One, 7 (10), e46117
DOI 10.1371/journal.pone.0046117

Yri OE, Ekstrom PO, Hilden V, Gaudernack G, Liestol K, Smeland EB, Holte H (2012)
Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma
Leuk. Lymphoma, 53 (10), 1934-1944
DOI 10.3109/10428194.2012.682307

Publications 2011

Huse K, Bakkebo M, Oksvold MP, Forfang L, Hilden VI, Stokke T, Smeland EB, Myklebust JH (2011)
Bone morphogenetic proteins inhibit CD40L/IL-21-induced Ig production in human B cells: Differential effects of BMP-6 and BMP-7
Eur. J. Immunol., 41 (11), 3135-3145
DOI 10.1002/eji.201141558

Publications 2010

Bakkebo M, Huse K, Hilden VI, Smeland EB, Oksvold MP (2010)
TGF-beta-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK
BMC Immunol., 11, 57
DOI 10.1186/1471-2172-11-57

Publications 2006

Hilden VI (2006)
Genetic polymorphisms in DNA repair genes, genomic instability and radiation response
Forfatteren, Bø, 91 s., XVI
BIBSYS 070101655